Abstract
Complement is an essential part of innate immunity as it participates in host defense against infections, disposal of cellular debris and apoptotic cells, inflammatory processes and modulation of adaptive immune responses. Several soluble and membrane-bound regulators protect the host from the potentially deleterious effects of uncontrolled and misdirected complement activation. Factor H is a major soluble regulator of the alternative complement pathway, but it can also bind to host cells and tissues, protecting them from complement attack. Interactions of factor H with various endogenous ligands, such as pentraxins, extracellular matrix proteins and DNA are important in limiting local complement-mediated inflammation. Impaired regulatory as well as ligand and cell recognition functions of factor H, caused by mutations or autoantibodies, are associated with the kidney diseases: atypical hemolytic uremic syndrome and dense deposit disease and the eye disorder: age-related macular degeneration. In addition, factor H binds to receptors on host cells and is involved in adhesion, phagocytosis and modulation of cell activation. In this review we discuss current concepts on the physiological and pathophysiological roles of factor H in light of new data and recent developments in our understanding of the versatile roles of factor H as an inhibitor of complement activation and inflammation, as well as a mediator of cellular interactions. A detailed knowledge of the functions of factor H in health and disease is expected to unravel novel therapeutic intervention possibilities and to facilitate the development or improvement of therapies.
Highlights
The Complement SystemInnate immunity is a first-line defense system, essential for the protection of the host against invading pathogens, acting immediately after infection and without previous antigen contact [1]
We found that extracellular matrix (ECM)-bound pentraxin 3 (PTX3) increases the recruitment of factor H and
Autoantibodies have been described in non–small cell lung cancer [142]; it is not yet known, whether this is due to an increased production of factor H and if and how these autoantibodies differ from those described in atypical hemolytic uremic syndrome (aHUS) and dense deposit disease (DDD)
Summary
Innate immunity is a first-line defense system, essential for the protection of the host against invading pathogens, acting immediately after infection and without previous antigen contact [1]. Factor H is the major fluid-phase regulator of the alternative pathway, as it prevents the formation of the C3 and C5 convertases, facilitates the disassembly of already formed convertases and acts as a cofactor for the inactivation (enzymatic cleavage) of C3b. Disturbances in this complex system caused by complement gene mutations, autoantibodies or exogenous triggers may tip the balance between complement activation and inhibition, resulting in an attack on self tissue [4,5]. This review summarizes the current concepts of the roles of factor H in health and disease and discusses open questions for future research
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
